Multivalent Conjugate Vaccines with Bivalent or Multivalent Conjugate Polysaccharides that Provide Improved Immunogenicity and Avidity

The disclosure describes compositions containing conjugates using novel linkers, bivalent polysaccharide conjugates, and methods of bivalent polysaccharide conjugation in the development of multivalent conjugate vaccines. Conjugation of capsular polysaccharides to carrier proteins is carried out using homo-bifunctional and/or hetero-bifunctional linkers of specific lengths. Incorporation of the linkers and their use in bifunctional linkers induces higher titers of functional antibodies with high avidity, eliciting higher immunologic memory, and reduced carrier protein effect. This provides immunochemically cross-reactive capsular polysaccharides wherein one or more cross-reactive capsular polysaccharides are conjugated sequentially or concurrently to carrier protein using bifunctional linkers bearing the same or different functional groups. Such a linker and the size of the capsular polysaccharides provides an effective multivalent conjugate vaccine with high antibody titers and a reduced carrier effect and results in reduction in the content of the capsular polysaccharide and protein per dose of vaccine which reduces reactogenicity..

Medienart:

Patent

Erscheinungsjahr:

2018

Erschienen:

2018

Enthalten in:

Europäisches Patentamt - (2018) vom: 13. Dez. Zur Gesamtaufnahme - year:2018

Sprache:

Englisch

Beteiligte Personen:

KAPRE SUBHASH V [VerfasserIn]
DATTA ANUP K [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61K: Preparations for medical, dental, or toilet purpose (...)
che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2018-12-13, Last update posted on www.tib.eu: 2024-03-06, Last updated: 2024-03-15

Patentnummer:

US2018353591

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA000031097